Cargando…
Colchicine for the prevention of ischemic stroke: An updated meta-analysis of randomized clinical trials
BACKGROUND: Inflammation is increasingly recognized as a target to reduce residual cardiovascular risk. Colchicine is an anti-inflammatory drug that was associated with improved cardiovascular outcomes. However, its effect on stroke reduction was not consistent across studies. Therefore, the aim of...
Autores principales: | Al-Atta, Ayman, Kuzemczak, Michał, Alkhalil, Mohammad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459694/ https://www.ncbi.nlm.nih.gov/pubmed/34667902 http://dx.doi.org/10.4103/bc.bc_24_21 |
Ejemplares similares
-
Meta‐Analysis of Intensive Lipid‐Lowering Therapy in Patients With Polyvascular Disease
por: Alkhalil, Mohammad, et al.
Publicado: (2021) -
An Updated Meta-Analysis of RCTs of Colchicine for Stroke Prevention in Patients with Coronary Artery Disease
por: Katsanos, Aristeidis H., et al.
Publicado: (2021) -
ACE inhibitor-related angioedema in a COVID-19 patient—a plausible contribution of the viral infection?
por: Kuzemczak, Michał, et al.
Publicado: (2021) -
Multivessel coronary thrombosis in a COVID-19 patient: Lungs are not always a culprit
por: Kuzemczak, Michał, et al.
Publicado: (2021) -
Colchicine for prevention of post-operative atrial fibrillation: Meta-analysis of randomized controlled trials
por: Ge, Peibing, et al.
Publicado: (2022)